Evidence map›Paper›PMID 27715386›Full record

ArticleAutophagy2016

BECN1/Beclin 1 sorts cell-surface APP/amyloid β precursor protein for lysosomal degradation.

Gayathri Swaminathan, Wan Zhu, Edward D Plowey

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Neurobiology of stress · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Autophagy Balances Neuroinflammation in Alzheimer's Disease.Cellular and molecular neurobiology · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Alzheimer's Disease and Protein Kinases.Advances in experimental medicine and biology · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gayathri Swaminathana Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Wan Zhua Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Edward D Ploweya Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA.
Stanford University · US

Funding

NMDA receptor trafficking by the autophagy regulatory protein beclin 1K08NS085324 · NINDS · STANFORD UNIVERSITY · PI PLOWEY, EDWARD D · 2014 to 2017
$717k
NINDS NIH HHS K08 NS085324
6 · The paper itself

Abstract

The regulation of plasma membrane (PM)-localized transmembrane protein/receptor trafficking has critical implications for cell signaling, metabolism and survival. In this study, we investigated the role of BECN1 (Beclin 1) in the degradative trafficking of PM-associated APP (amyloid β precursor protein), whose metabolism to amyloid-β, an essential event in Alzheimer disease, is dependent on divergent PM trafficking pathways. We report a novel interaction between PM-associated APP and BECN1 that recruits macroautophagy/endosomal regulatory proteins PIK3C3 and UVRAG. We found that BECN1 promotes surface APP internalization and sorting predominantly to endosomes and endolysosomes. BECN1 also promotes the targeting of a smaller fraction of internalized APP to LC3-positive phagophores, suggesting a role for BECN1-dependent PM macroautophagy in APP degradation. Furthermore, BECN1 facilitates lysosomal degradation of surface APP and reduces the secretion of APP metabolites (soluble ectodomains, sAPP). The association between APP and BECN1 is dependent on the evolutionarily conserved domain (ECD) of BECN1 (amino acids 267-337). Deletion of a BECN1 ECD subregion (amino acids 285-299) did not impair BECN1- PIK3C3 interaction, PtdIns3K function or macroautophagy, but was sufficient to impair the APP-BECN1 interaction and BECN1's effects on surface APP internalization and degradation, resulting in increased secretion of sAPPs. Interestingly, both the BECN1-APP association and BECN1-dependent APP endocytosis and degradative trafficking were negatively regulated by active AKT. Our results further implicate phosphorylation of the BECN1 Ser295 residue in the inhibition of APP degradation by AKT. Our studies reveal a novel function for BECN1 in the sorting of a plasma membrane protein for endolysosomal and macroautophagic degradation.

Indexed as

ProteolysisAmyloid beta-Protein PrecursorAutophagosomesBeclin-1Cell MembraneEndocytosisHEK293 CellsHumansLysosomesMetabolomeModels, BiologicalMutant ProteinsPhosphatidylinositol 3-KinasesProtein BindingProtein DomainsProtein TransportAmyloid beta-Protein PrecursorBeclin-1Mutant ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAKTamyloid βBeclin 1plasma membraneprecursor proteinsorting

Identifiers

PMID27715386
PMCPMC5173276
OpenAlexW2529526688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.